Immunohistochemical analysis indicated decreased expression of COX-2 and caspase-3 in cardamonin-treated groups, suggesting its protective effects against AA-induced colitis by mitigating inflammation, oxidative stress, and apoptosis. This evidence concerns the gene CASP3 and colitis.